Treatment of noninvasive carcinoma: Fifteen-year results at the national cancer center hospital in Tokyo

被引：13

作者：

Akashi-Tanaka S. ^{[1
]}

Fukutomi T. ^{[1
]}

Nanasawa T. ^{[1
]}

Matsuo K. ^{[1
]}

Hasegawa T. ^{[2
]}

Tsuda H. ^{[2
]}

机构：

[1] Division of Breast Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo 104-0045

[2] Pathology Division, National Cancer Center Research Institute

来源：

Breast Cancer | 2000年 / 7卷 / 4期

关键词：

Breast cancer; Ductal carcinoma in situ; Lobular carcinoma in situ; Long term result;

D O I：

10.1007/BF02966402

中图分类号：

学科分类号：

摘要：

The introduction of screening mammography (MMG) will lead to increased detection of preclinical early breast cancer in Japan. It has become more important to understand the nature of these lesions. We tried to elucidate the long term prognosis and clinical and pathological characteristics of noninvasive cancers. A total of 336 (5.4%) ductal carcinoma in situ (DCIS) and 32 (0.5%) Iobular carcinoma in situ (LCIS) were diagnosed in 6 277 breast carcinomas at the National Cancer Center Hospital from 1962 to 1995. Most (80%) LCIS occurred in premenopausal women. LCIS has significantly higher bilaterality than that of DCIS. Local recurrence occurred in approximately 10% of patients after breast conserving surgery for DCIS and LCIS. Four patients died of breast carcinoma, which were initially diagnosed as noninfiltrating carcinoma. The 15-year cause specific survival rates of patients with DCIS and LCIS were 98.5 % and 100 %, respectively.

引用

页码：341 / 344

页数：3

共 15 条

[1]

Schwartz G.F., Solin L.J., Olivotto I.A., Ernster V.L., Pressman P.I., The consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999, Human Pathology, 31, 2, pp. 131-139, (2000)

[2]

Frykberg E., Bland K., In situ breast carcinoma, Advances in Surgery, 26, pp. 29-72, (1993)

[3]

Fisher B., Dignam J., Wolmark N., Mamounas E., Costantino J., Poller W., Fisher E.R., Wickerham D.L., Deutsch M., Margolese R., Dimitrov N., Kavanah M., Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B- 17, Journal of Clinical Oncology, 16, 2, pp. 441-452, (1998)

[4]

Solin L.J., Recht A., Fourquet A., Et al., Ten-year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast, Cancer, 68, pp. 2337-2344, (1991)

[5]

Andersen J.A., Lobular carcinoma in situ of the breast. An approach to rational treatment, Cancer, 39, 6, pp. 2597-2602, (1977)

[6]

Haagensen C.D., Bodian C., Haagensen D.E., Lobular neoplasia (lobular carcinoma in situ), Haagensen CD Bodian C Haagensen de Eds Breast Carcinoma: Risk and Detection, pp. 238-292, (1981)

[7]

Page D.L., Kidd T.E., Dupont W., Et al., Lobular neoplasia of the breast: Higher risk for subsequent invasive cancer predicted by more extensive disease, Hum Pathol, 22, pp. 1232-1239, (1991)

[8]

Wheeler J.E., Enterline H.T., Roseman J.M., Et al., Lobular carcinoma in situ of the breast: Long-term followup, Cancer, 34, pp. 554-563, (1974)

[9]

Rosen P.P., Lieberman P.H., Braun Jr. D.W., Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years, American Journal of Surgical Pathology, 2, 3, pp. 225-251, (1978)

[10]

Simmons R.M., Osborne M.P., The evaluation of high risk and pre-invasive breast lesions and the decision process for follow up and surgical intervention, Surgical Oncology, 8, 2, pp. 55-65, (1999)

← 1 2 →